BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 9107552)

  • 1. Depletion of glutathione in the kidney and the renal disposition of administered inorganic mercury.
    Zalups RK; Lash LH
    Drug Metab Dispos; 1997 Apr; 25(4):516-23. PubMed ID: 9107552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of inorganic mercury following biliary obstruction and chemically induced glutathione depletion: dispositional changes one hour after the intravenous administration of mercuric chloride.
    Zalups RK; Barfuss DW; Lash LH
    Toxicol Appl Pharmacol; 1999 Jan; 154(2):135-44. PubMed ID: 9925797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basolateral uptake of inorganic mercury in the kidney.
    Zalups RK
    Toxicol Appl Pharmacol; 1998 Jul; 151(1):192-9. PubMed ID: 9705903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between alterations in glutathione metabolism and the disposition of inorganic mercury in rats: effects of biliary ligation and chemically induced modulation of glutathione status.
    Zalups RK; Barfuss DW; Lash LH
    Chem Biol Interact; 1999 Dec; 123(3):171-95. PubMed ID: 10654838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation and handling of inorganic mercury in the kidney after coadministration with glutathione.
    Zalups RK; Barfuss DW
    J Toxicol Environ Health; 1995 Apr; 44(4):385-99. PubMed ID: 7723072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organic anion transport and action of gamma-glutamyl transpeptidase in kidney linked mechanistically to renal tubular uptake of inorganic mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1995 Jun; 132(2):289-98. PubMed ID: 7785056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luminal and basolateral mechanisms involved in the renal tubular uptake of inorganic mercury.
    Zalups RK; Minor KH
    J Toxicol Environ Health; 1995 Sep; 46(1):73-100. PubMed ID: 7666495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal disposition of mercury in rats after intravenous injection of inorganic mercury and cysteine.
    Zalups RK; Barfuss DW
    J Toxicol Environ Health; 1995 Apr; 44(4):401-13. PubMed ID: 7723073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystine alters the renal and hepatic disposition of inorganic mercury and plasma thiol status.
    Zalups RK; Lash LH
    Toxicol Appl Pharmacol; 2006 Jul; 214(1):88-97. PubMed ID: 16466761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversion or prevention of biliary outflow from the liver diminishes the renal uptake of injected inorganic mercury.
    Zalups RK; Barfuss DW
    Drug Metab Dispos; 1996 Apr; 24(4):480-6. PubMed ID: 8801064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basolateral uptake of mercuric conjugates of N-acetylcysteine and cysteine in the kidney involves the organic anion transport system.
    Zalups RK
    J Toxicol Environ Health A; 1998 Sep; 55(1):13-29. PubMed ID: 9747601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study on the effects of BSO, GSH, vitamin C and DMPS on the nephrotoxicity induced by mercury].
    Zhao-Fa X; Jing-Hua Y; Jia-Ming Y; Zhong-Wei Y
    Wei Sheng Yan Jiu; 2005 Sep; 34(5):533-6. PubMed ID: 16329589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced renal outer medullary uptake of mercury associated with uninephrectomy: implication of a luminal mechanism.
    Zalups RK
    J Toxicol Environ Health; 1997 Feb; 50(2):173-94. PubMed ID: 9048960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductions in renal mass and the nephropathy induced by mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):366-79. PubMed ID: 9144453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive losses of renal mass and the renal and hepatic disposition of administered inorganic mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):121-31. PubMed ID: 7839359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubular secretion and reabsorption of mercury compounds in mouse kidney.
    Tanaka-Kagawa T; Naganuma A; Imura N
    J Pharmacol Exp Ther; 1993 Feb; 264(2):776-82. PubMed ID: 8094752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small aliphatic dicarboxylic acids inhibit renal uptake of administered mercury.
    Zalups RK; Barfuss DW
    Toxicol Appl Pharmacol; 1998 Jan; 148(1):183-93. PubMed ID: 9465278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous coexposure to inorganic mercury and cadmium: a study of the renal and hepatic disposition of mercury and cadmium.
    Zalups RK; Barfuss DW
    J Toxicol Environ Health A; 2002 Oct; 65(19):1471-90. PubMed ID: 12396877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of uninephrectomy and mercuric chloride on renal glutathione homeostasis.
    Zalups RK; Lash LH
    J Pharmacol Exp Ther; 1990 Sep; 254(3):962-70. PubMed ID: 2395124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.